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The Contribution of Heart Failure to Sleep Disturbances and Depressive
Symptoms in Older Adults
Abstract
Background:
The aim of this study was to explore the associations between physical symptoms, sleep disturbances,
and depressive symptoms in community-dwelling elderly individuals, comparing persons with and without
heart failure (HF).
Methods:
A total of 613 older adults (mean age 78 years) underwent clinical and echocardiographic examinations.
Questionnaires were used to evaluate sleep disturbances and depressive symptoms. A model was
developed in those with HF (n = 107) and compared with those without HF (n = 506).
Results:
Cardiopulmonary symptoms (ie, dyspnea and nighttime palpitations) and pain had significant direct
associations with sleep disturbances, which indirectly affected depressive symptoms. The model was
essentially the same in those with and without HF except that the effect of sleep disturbances on
depressive symptoms was stronger in those with HF (β = 0.64 vs β = 0.45, P = .006).
Conclusion:
In community-dwelling older adults, regardless of their diagnosis, physical symptoms had a direct effect
on sleep disturbances and an indirect effect on depressive symptoms.
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Abstract
Background: The aim of this study was to explore the associations between physical
symptoms, sleep disturbances and depressive symptoms in community dwelling elders,
comparing persons with and without heart failure (HF).
Methods: 613 older adults (mean age 78 years) underwent clinical and echocardiographic
examination. Questionnaires were used to evaluate sleep disturbances and depressive
symptoms. A model was developed in those with HF (n=107) and compared in those without
HF (n=506).
Results: Cardiopulmonary symptoms (i.e. dyspnoea and night-time palpitations) and pain had
significant direct associations with sleep disturbances, which indirectly affected depressive
symptoms. The model was essentially the same in those with and without HF except that the
effect of sleep disturbances on depressive symptoms was stronger in those with HF (β=0.64
vs. β=0.45, p=0.006).
Conclusion: In community dwelling older adults, regardless of their diagnosis, physical
symptoms had a direct effect on sleep disturbances and an indirect effect on depressive
symptoms.
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Background
Chronic heart failure (HF) is common in the general population and the prevalence rises with
age.1 Today the mean age for community dwelling HF patients is at least 75 years.2 In patients
with HF, both sleep disturbances3 and depression are common.4 Sleep disturbances and
depression seem to be intertwined. Treatment of depression usually improves sleep, whereas
treatment of insomnia can decrease the risk of relapse or recurrence of depression.5
The symptoms of insomnia, including difficulties maintaining sleep (DMS), difficulties
initiating sleep (DIS), and non restorative sleep (NRS) are commonly reported by the general
population.8 In a survey of adults older than 18 years, 21% complained of DIS, 16% of DMS,
and 11% of NRS at least three times a week during the last month or more.9 In Sweden, where
this study was conducted on adults aged 65-79 years, 36%, 43% and 32% reported complaints
of DIS, DMS and NRS.10 Sleep problems are particularly prevalent in HF patients, with
almost 60% reporting trouble sleeping or not getting enough of sleep at least 3-4 times a
week.3 In a study by Broström et al.13 DMS was the most commonly reported insomnia
symptom, with major complaints reported by 23% of the men and 20% of the women.
As people age, sleep becomes even more fragmented with increasing amounts of time spent in
superficial sleep non rapid eye movement sleep (NREM) stage 1 and 2, less time in deep,
slow wave sleep (NREM stage 3 and 4) and rapid eye movement sleep (REM) sleep 6. Signs
of disrupted circadian regulation of sleep can also be seen with aging, with older people
tending to experience increased sleep onset latency, more nightly awakenings, and a
decreased total sleep time compared to younger people.7 Physical symptoms may be
responsible for some of the sleep disturbances experienced with aging. Symptoms such as
dyspnoea, palpitations and pain commonly disturb sleep in HF patients.15-16 However, many
of these problems are responsible for disturbed sleep in older adults without HF as well.17-18

Another health problem common in the general population that is associated with aging and
linked to sleep disturbances is depressive symptoms such as anhedonia, lack of energy and
weight changes.11 In a Norwegian epidemiological study Stordal et al. found that the
occurrence of depressive symptoms as measured by the Hospital Anxiety Depression scale
(HADS) increased from 4% of men and women aged 20-29 years, to 14% of those aged 60-69
years, to 17% of those aged 70-79 years. In those aged 80-89 years, depressive symptoms
were found in 23% of the men and 18% of the women.12 Approximately 30-40% of HF
patients have depressive symptoms.19 Factors known to predict depressive symptoms in HF
patients include poor health perceptions, alcohol abuse, economic burden associated with
medical care and living alone. However, not all of the depressive symptoms of HF can be
explained by this aggregate.20 Disturbed sleep confers approximately a two to threefold
increase in the risk of depressive symptoms in HF patients.14 Importantly, depressive
symptoms have been found to mediate the effects of sleep disturbances on health related
quality of life.11
The relationships between physical symptoms, sleep disturbances, and depressive symptoms
have not been extensively evaluated in community dwelling older adults with or without HF.
Knowledge about these associations is important in the design of interventions. If these
relationships are only evident in HF patients, HF programs should integrate approaches
designed to improve sleep and/or depressive symptoms. But, if these relationships are generic
in all older adults, interventions can be designed to address physical symptoms, regardless of
the medical diagnosis. The aim of this study therefore was to explore the associations between
physical symptoms, sleep disturbances, and depressive symptoms in community dwelling
older adults with and without HF.

Methods
Sample
The patient population was derived from the CoroKind study and has been described
previously.21 In brief, the major aim of the parent study was to evaluate the prevalence of HF
among community dwelling older adults. The study took place between 1998 to 2000. All
subjects were aged 65-82 years and lived in a rural community with 10 300 inhabitants in the
southeast of Sweden. All inhabitants in the age span mentioned above were invited to clinical
and echocardiographic examinations. The rationale for this unusual age span is that some
people agreed to participate only if their younger or older spouse could be examined as well.
Of 1130 individuals in the targeted age range, 876 agreed to participate (participation rate
78%). From January 2003 to June 2005 the cohort was again contacted by telephone by a
research nurse and invited to repeat their clinical and echocardiographic examinations. A total
of 675 subjects (77% of the original cohort) agreed to participate. The reasons for not
participating were death (12%), having moved to nursing homes or other parts of Sweden
(3%), declined (7%) and not showing up (1%). All participants provided informed written
consent. The study protocol was approved by the Ethics Committee at the Faculty of Health
Sciences, University of Linköping, Sweden, and is in accordance with the provisions of the
Helsinki declaration.
Clinical Examination
For this follow-up study all participants were examined by a cardiologist and given a package
of self-report instruments to be returned by mail. The cardiologist took a patient history and
performed a clinical examination, including symptoms and signs of HF. To reduce bias, the
cardiologist was blinded to the results of the prior examinations and echocardiography.
Doppler echocardiographic examinations were performed to assess left ventricular ejection

fraction (LVEF). Global systolic function was determined semi-quantitatively and classified
into three groups. In this study, LVEF ≥ 50% corresponded to normal systolic function and
LVEF≤ 49% corresponded to at least mildly impaired systolic function. In the present study,
the cardiologists in the author group (UA and UD) assessed the presence of HF. All subjects
who had at least mildly impaired systolic function (LVEF <=49%) and had clinical signs and
symptoms of HF were considered to have HF.

Individual comorbid conditions were identified by the cardiologist during the clinical
examination. Diabetes mellitus was defined as ongoing treatment for diabetes or fasting blood
glucose ≥ 7 mmol/L. Hypertension was defined as a previous physician diagnosis or blood
pressure of more than 140/90 mm Hg. Ischemic heart disease (IHD) was defined as a history
of angina pectoris and/or myocardial infarction and/or coronary angioplasty and/or coronary
bypass surgery. Previous or present tumour was defined by history. A respiratory disease was
established if the participant had a diagnosis of or was undergoing treatment for chronic
pulmonary disease or asthma.
Physical signs and symptoms and Sleep disturbances
Items from the 26 item Uppsala Sleep Inventory (USI)-HF questionnaire were used to
measure physical symptoms and sleep disturbances.13 The USI has previously been used in
surveys of both younger and elderly people, as well as in patients with HF. 10, 13, 22 In
development, the content in the USI-HF was scrutinized and revised by an expert panel
consisting of sleep researchers, cardiologist and HF nurses. The USI-HF measures five
dimensions: sleep complaints; physical and emotional arousals; daytime symptoms; sleep
need; and sleep disruption. Chronbach alpha has been reported to be 0.75.13 In the present
study items measuring the insomnia symptoms of DIS, DMS and NRS were used. On these

items the respondents rate their problems on a Likert scale ranging from no problems (1)
small problems (2) moderate problems (3) great problems (4) to very great problems (5).
Estimates of the number of nocturnal awakenings and hypnotic uses were also included as
indicators of sleep disturbances.The USI-HF items measuring problems with nocturnal
dyspnoea, palpitations and pain were used as indicators of physical symptoms. These items
are answered as never (1) seldom (2) sometimes (3) often (4) or very often (5).
Depressive symptoms
Depressive symptoms were measured with the Hospital Anxiety Depression scale (HADS).23
To prevent noise from somatic diseases the instrument only focuses the affective symptoms of
depression (i.e. depressed, sad mood and diminished interest or pleasure in activities).23 The
HADS is frequently used in different types of settings (e.g., community care, primary care
and hospital wards) and in different patient groups.24 The HADS scores range from 0-21, with
higher scores indicating more symptoms of depression.23 The HADS has been found to be a
reliable tool. Psychometric testing supports two factor solution (anxiety and depression). The
sensitivity and specificity was approximately 0.80 for both subscales,30 supporting
discriminant validity of the HADS. Chronbach’s alpha for the HADS was 0.82.30 In the
present study the HADS was used as a continuous measure in statistical analyses.
Statistical analysis
Both descriptive statistics and structural equation modeling (SEM) were used to analyse the
data in the present study. Spearman correlation was used to analyse the bivariate associations
between the manifest variables representing physical symptoms, sleep disturbances and
depressive symptoms. SEM was used to explore the relationships between physical
symptoms, sleep disturbances and depressive symptoms in participants with and without HF.

SEM was used because it permits analysis and modeling of complex inter-relationships
among a number of inter-dependent variables. In the SEM analysis measured variables are
factored to latent variables and assumed paths between the constructs are tested. A conceptual
model of the associations of physical symptoms, sleep disturbances and depressive symptoms
was developed based on earlier HF studies and used to guide the SEM analysis.3, 14-16, 25 In
this theoretical model we assumed that HF was a cause for the physical symptoms of
dyspnoea, palpitations, pain. These symptoms were assumed to be linked with depressive
symptoms through the symptoms of insomnia, nocturnal awakenings, and use of hypnotics.
The summary score from the HADS was used to indicate depressive symptoms.
The model of physical symptoms (i.e. dyspnoea, palpitations and pain), sleep disturbances
and depressive symptoms was tested in participants with and without HF using SEM.
Associations between the latent variables were derived using maximum likelihood and
described with their standardized coefficients.To assess goodness of fit we used the chi-square
value, the Root Mean Square Error of Approximation (RMSEA) and the Comparative Fit
Index (CFI). In general terms fit indices provide estimates of how well the model would
represent our population of community dwelling elderly with and without HF. An
insignificant chi-square would indicate a good model fit. An overall RMSEA below 0.06
indicates a good fit whereas a CFI ≥ 0.95 is considered a good fit indicating that at least 95
percent of the covariation in the data is reproduced by the model. Modification indices were
used to modify the model only if these modifications were theoretically justified. The
modification index estimates the decrease in the chi-square value that would result if a given
parameter is added to the model.26
Descriptive and comparative analyses were performed with the SPSS version 18.0 whereas
SEM analyses were performed with the LISREL 8.30 software. A p < 0.05 in the SPSS

analyses and t-value of ≥ 1.96 for factor loadings and effects in the LISREL analyses were
considered significant.

Results
Of 675 participants investigated, a total of 613 (91%) had data on echocardiography, physical
symptoms, sleep disturbances and depressive symptoms available for analysis. Table 1
describes baseline characteristics of the studied sample. The mean age of sample was 78 years
and 47% were males. A total of 107 participants (17%) clearly had HF; these participants with
HF were older (79 years vs. 77 years, p=0.001) and more of them were male (71% vs. 43%,
p=0.001) compared to those without HF. Those with HF had higher median plasma creatinine
concentration (84 µmol/L vs. 73 µmol/L, p=0.001) and more diabetes (25% vs. 14%,
p=0.005) and ischemic heart disease (50% vs. 21%, p=0.001) than those without HF. More of
those with HF had two or more co-morbidities (64% vs. 36%, p=0.001) and had more
treatment with ACE/ARB (39% vs. 23%, p=0.001), B-blockers (55% vs. 32%, p=0.001) and
diuretics 46% vs. 33%, p=0.012). No differences between those with and without HF were
found regarding antidepressant medication and hypnotic use.

Bivariate associations physical symptoms, sleep disturbances and depressive symptoms in
participants with and without heart failure.
Table 2 and 3 and presents the associations of physical symptoms, sleep disturbances and
depressive symptoms in participants with and without HF. In those with HF the physical
symptoms (i.e. dyspnoea, palpitations and pain) correlated significantly to each others as well
as to nocturnal awakenings, insomnia symptoms and depressive symptoms. Awakenings

correlated most strongly with the insomnia symptoms (r=0.360-0.401). Generally the same
associations and magnitudes of correlations were found in those without HF as well.
Hypnotics correlated with DMS and NRS in those with HF and with DIS, DMS and NRS in
those without HF. In those with HF the highest correlation was found between the insomnia
symptoms NRS and DIS (r=0.559) whereas in those without HF the highest correlation of
0.554 was between NRS and DMS. No signs of multicollinearity were found from
inspection of the correlation plots, violation inflation factors or tolerance statistics.

Modelling the associations between physical symptoms, sleep disturbances and depressive
symptoms in participants with and without heart failure
We first created a SEM model that explored the relationships between physical symptoms,
sleep disturbances and depressive symptoms in participants with HF. In the next step this
model was tested in the group without HF. The associations between dyspnoea, palpitations,
pain, sleep disturbances and depressive symptoms were then analyzed. The initial SEM
analysis in participants with HF did not fully confirm the assumed paths and the fit from the
model were not acceptable. After scrutinizing the data and suggested modification indices, the
single variables of night-time dyspnoea and palpitations were amalgamated into one latent
factor labeled cardiopulmonary symptoms.
The new model, shown in Figure 2, fit the data well in those with HF. Examination of the fitindices showed that the model explained the covariances between the manifest variables
almost completely. Indirect and total effects between the factors in the model are shown in
Table 4. In those with HF we found moderate direct effects of cardiopulmonary symptoms
and pain on sleep disturbances (β=0.38 and β=0.37). Sleep disturbances had a strong effect

(β=0.64) on depressive symptoms. By these paths, cardiopulmonary symptoms and pain had
moderate indirect effects on depressive symptoms (β=0.24 and β=0.24).
The model also fit well in those without HF (Figure 3). In this model, cardiopulmonary
symptoms had a moderate effect on sleep disturbances (β=0.30) and there was a moderate
effect of sleep disturbances on depressive symptoms (β=0.45). The indirect effect of
cardiopulmonary symptoms on depressive symptoms was small (β=0.13). Comparing these
effects to the model of those with HF illustrated that the path between sleep disturbances and
depressive symptom was significantly lower in those without HF (β=0.45 vs. β=0.64,
p=0.006). The direct effect of pain on sleep disturbances and the indirect effect of pain on
depressive symptoms was however of almost the same magnitude as in those with HF (β=0.40
and β=0.18).

Discussion
In the present study of community dwelling older adults with and without HF we found that
the physical symptoms of dyspnea, palpitations (cardiopulmonary symptoms) and pain were
directly associated sleep disturbances, which led to an indirect association to depressive
symptoms. These results suggest that interventions focused on the relief of physical symptoms
may decrease sleep disturbances and depressive symptoms, regardless of the medical
diagnosis. Further, depressive symptoms in older adults should be approached as indicators of
a potentially modifiable condition—impaired sleep.
We found that cardiopulmonary symptoms were directly associated with sleep disturbances
and indirectly associated with depressive symptoms in those with and without HF. Others
have shown that wheezing or whistling from chest at night is a common sleep disturbance
among older adults and associated with daytime sleepiness.27 The only difference we found in
those with HF was that the associations between cardiopulmonary symptoms, sleep

disturbances and depressive symptoms were stronger. Cardiopulmonary symptoms may signal
sleep disordered breathing (SDB), which is common in community dwelling elders, but even
more common among elders with HF.28 SDB is known to cause nocturia29 and disturbed sleep
and in older adults severe SDB has been shown to cause daytime sleepiness.27 It is known that
SDB in HF is associated with increased risk for having daytime and night time ventricular
arrhythmias30 as well as to cause choking spells and hyperventilation during sleep.31 SDB
may therefore be a potential explanation for the stronger associations between
cardiopulmonary symptoms, sleep disturbances and depressive symptoms in the HF model.
The association between SDB and self-reported sleep quality in HF patients, however,
remains unclear at this time. Redeker and colleagues showed only a weak association between
SDB and self-reported sleep in 170 HF patients, despite the fact that SDB was associated with
poorer objectively measured sleep quality.32 In two smaller studies of HF patients, however,
one found that SDB was associated with poorer subjectively rated sleep quality and
depressive symptoms,33 whereas in the other study, SDB was associated with poor quality of
life.34 Patients with HF and SDB successfully treated with Continuous Positive Airway
Pressure (CPAP) have been found to have reductions in night time ventricular arrhythmias.35
However, the extent of which CPAP treatment of SDB in older adults with as well as without
HF can improve cardiopulmonary symptoms, sleep disturbances or depressive symptoms is
unclear.
As many as 75% of community dwelling elderly report some pain, of these 52% report daily
pain.36 Despite this, pain is seldom included as a variable in studies investigating correlates or
predictors of sleep in community dwelling elderly.17, 37-38 In the present study pain during the
night was associated with sleep disturbances and depressive symptoms, and the magnitude of
the relationship was the same in those with and without HF. A recent study showed that older
adults reporting severe pain had an increased risk for poor sleep.39 Furthermore, in older

adults, pain or physical discomfort at night has been found to be a strong predictor for
daytime sleepiness.27 Pain and sleep disturbances seem to have a complex relationship. In an
experimental study of healthy volunteers, disrupted sleep was shown to have a hyper
analgesic effect whereas recovery sleep was associated with analgesic effects.40 A population
based study of adults aged 25-65 years showed that baseline self-reported good sleep was a
predictor for the resolution of pain at 15 months follow-up.41
The results of this study suggest that reducing cardiopulmonary symptoms, pain and/or sleep
disturbances are important interventions. Pharmacological treatments of pain and sleep
problems should however be carefully selected and monitored because of the risk of
polypharmacy and side-effects such as sedation, drowsiness and somnolence.27, 42 Further,
sleep medications cause depression in older adults, independent of insomnia.43 Older adults
with HF may be in particular vulnerable for pharmacological side effects. In individuals aged
80 years and older, HF medications such as beta-blockers, diuretics and ACE/ARB, have been
associated with insomnia.44 More than two thirds of HF patients have been found to
experience an adverse drug event and these patients also report more sleeping problems
compared to those who have not experienced an adverse drug event.45 Adverse drug events
may provide another explanation for the stronger association between sleep disturbances and
depressive symptom in those with HF. Assessment of disturbed sleep as a potential side-effect
of the pharmacological treatment is important because simply adjusting dosages may improve
sleep quality. A nonpharmacologic treatment of pain could be CPAP. A small study in older
adults with SDB found that CPAP therapy had analgesic effects as well as improving
respiratory parameters.46 Cognitive behavioural therapy (CBT) is another potential approach
to pain, sleep disturbances, and depressive symptoms. In older adults with arthritis or chronic
obstructive lung disease and insomnia, CBT has been found to improve sleep and pain.47-48 In
patients with HF, mindfulness meditation improves depressive symptoms and health-related

quality of life.49 However, the numbers of CBT studies performed on older adults with and
without HF are small and few and more large scaled studies are needed.

Limitations
Depressive symptoms overlap with some physical symptoms such as fatigue and problems
with appetite, which complicates the interpretation of findings. For this reason we chose the
HADS because it was specifically developed for measuring depressive symptoms in people
with different types of chronic diseases. Moreover studies have shown that the somatic
symptom profile of patients with HF and other chronic diseases and depression is similar to
that of people with depression only.50-51 However, the association between insomnia and
depression is complex, both among individuals with heart failure and those without.
And, paths in a SEM analysis can be directed in different ways. SEM is most useful in
testing a theory-based model, as specified in this study.3, 14-16, 25 Creating separate models
investigating different solutions for individuals with and without HF was important so
that we could identify generic responses versus those that are specific to heart failure.
Although our model produced a good fit, the study was limited in that the crosssectional data limits the possibility of identifying causal directionality. We also used selfreported symptoms of depression and disturbed sleep instead of objective clinical data
on sleep and depressive disorders. Many patients who would not meet the diagnostic
criteria for either of these disorders nevertheless may have scored high on the
questionnaires used in the study. Some of the attrition was due to death or moving to
nursing homes; HF, sleep disturbances, and/or depression may have played a role in these
events. Consequently, a model fitted on data from the remaining subjects may therefore be
biased in ways that would be difficult to ascertain. An advantage with the study design was

that it allowed us to explore the associations between physical symptoms, sleep disturbances
and depressive symptoms in participants with and without HF who were of the same age and
living in the same area. Another advantage was that all participants were examined by an
experienced cardiologist, both clinically and with Doppler echocardiography.
Echocardiography data were incomplete for 9% of the sample and these subjects were
deleted from the analysis since multiple imputation on data such as echocardiography
can be misleading. We think therefore that despite the limitations, this study can offer
important information regarding the impact of physical symptoms on sleep disturbances and
depressive symptom in community dwelling older adults.

Conclusion
In older adults living in the community, with and without HF, cardiopulmonary symptoms
and pain were directly associated with sleep disturbances, which led to a relationship between
physical and depressive symptoms. Sleep disturbances were more strongly associated with
depressive symptoms in older adults with HF, suggesting that poor sleep may be a particularly
important area for focus in this population in which depression is so common. Screening for
sleep disturbances and depression may alert clinicians to the presence of night time physical
symptoms in older adults. Pharmacological and/or non-pharmacological interventions can be
used to reduce cardiopulmonary symptoms and/or pain as well as sleep disturbances and/or
depressive symptoms. We recommend that clinicians assess the side-effects of cardiovascular
drugs on patients’ sleep and tailor the treatment regimen in those patients who have sleeping
problems. Future research is needed testing the impact of CPAP for SDB on physical
symptoms, sleep, and depressive symptoms. The results of this study illustrate that
interventions focused on addressing symptoms, regardless of the medical diagnosis, may

improve sleep quality and depressive symptoms in older adults. However large randomised
controlled studies are however needed to evaluate the effect of such programs.
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Tables
Table 1. Background characteristics for the study population with or without heart failure

Total
(n=613)

HF
(n=107)

No HF
(n=506)

Age, mean (SD)

78 (4)

79 (4)

77 (4)

0.001

Male, sex, % (n)

47 (289)

71 (67)

43 (218)

0.001

Body mass index, mean (SD)

27.1 (4.2)

27.4 (4.2)

27.0 (4.2)

0.33

Systolic blood pressure, mean (SD)

149 (23)

149 (19)

149 (24)

0.85

Diastolic blood pressure, mean (SD)

75 (11)

75 (10)

75 (12)

0.91

Diabetes, % (n)

99 (16)

25 (27)

14 (72)

0.005

Hypertension, % (n)

474 (78)

76 (80)

78 (394)

0.56

Ischemic heart disease, % (n)

26 (161)

50 (54)

21 (107)

0.001

Previous or present tumour, % (n)

16 (100)

20 (21)

16 (79)

0.31

Respiratory disease, % (n)

15 (93)

19 (20)

14 (73)

0.27

≥ 2 co morbidities, % (n)

46 (284)

64 (68)

36 (38)

0.001

Creatinine µmol/L , median (25th-75th quart)

74 (63-90)

84 (70-107)

73 (61-87)

0.001

LVEF<50%, % (n)

132 (22)

107 (100)

5 (25)

0.001

ACE/ARB, % (n)

26 (158)

39 (42)

23 (116)

0.001

B-blockers, % (n)

36 (222)

55 (59)

32 (163)

0.001

Diuretics, % (n)

35 (216)

46 (49)

33 (167)

0.012

Antidepressants, % (n)

4 (24)

2 (2)

22 (4)

0.41

Hypnotics, % (n)

6 (35)

8 (8)

5(27)

0.38

Note:ACEI/ARB – Angiotensin converting inhibitor/Angiotensin receptor blockers: LVEF –
Left ventricular ejection fraction

Table 2. Bivariate correlations physical symptoms, factors that disturb sleep and depressive symptoms in participants with heart failure (n=107)
#Awake

Dyspnoea

Palpitations

Pain

night-time

night-time

night-time

DMS

NRS

DIS

Depressive
symptoms

Antidepressants

#Awake

1

Dyspnoea
night-time

0.195*

1

Palpitations
night-time

0.300 **

0.419***

1

Pain
night-time

0.361***

0.204*

0.377***

1

DMS

0.401***

0.191*

0.209*

0.346***

1

NRS

0.362***

0.267**

0.402***

0.413***

0.495***

1

DIS

0.360***

0.128

0.240*

0.276***

0.341***

0.559***

1

Depressive
symptoms
Antidepressants

0.213 *

0.238*

0.374***

0.231*

0.264**

0.470***

0.322**

1

0.007

0.06

0.006

-0.049

0.007

0.027

0.056

0.069

1

Hypnotics

0.07

-0.002

0.041

0.095

0.215*

0.252**

0.157

0.143

-0.039

Note: DIS – Difficulties initiating sleep; DMS – Difficulties maintaining sleep;NRS – Non restorative sleep.
*p<0.05; **p<0.01, p<0.001***

Hypnotics

1

Bivariate correlations physical symptoms, factors that disturb sleep and depressive symptoms in participants without heart failure (n=504)
#Awake

Dyspnoea

Palpitations

Pain

night-time

night-time

night-time

DMS

NRS

DIS

Depressive
symptoms

Antidepressants

#Awake

1

Dyspnoea
night-time

0.195***

1

Palpitations
night-time

0.159***

0.442***

1

Pain
night-time

0.305***

0.292***

0.313***

1

DMS

0.541***

0.243***

0.211***

0.328***

1

NRS

0.343***

0.304***

0.248***

0.372***

0.554***

1

DIS

0.247***

0.192***

0.168***

0.268***

0.422***

0.474***

1

Depressive
symptoms
Antidepressants

0.176***

0.222***

0.171***

0.207***

0.212***

0.324***

0.160***

1

-0.023

0.029

0.065

0.045

0.051

0.166***

0.098*

0.074

1

Hypnotics

0.023

-0.054

0.113*

0.098*

0.179***

0.197***

0.235***

0.079

0.165**

Note: DIS – Difficulties initiating sleep; DMS – Difficulties maintaining sleep;NRS – Non restorative sleep.
*p<0.05; **p<0.01, p<0.001***

Hypnotics

1

Table 4. Significant indirect and total effects (β) between factors in the structural equation model in participants with heart failure. Indirect effect
is the difference between the direct and total effect.

HF group

Cardiopulmonary
Symptoms
Pain
Sleep disturbances
Non HF group
Cardiopulmonary
Symptoms
Pain
Sleep disturbances

Sleep
disturbances

Depressive
Symptoms

Ind.
effect
-

Tot.
effect
0.38

Ind.
effect
0.24

Tot.
effect

0.37

0.24

0.24

-

-

0.64

0.30

0.13

0.13

0.40

0.18

0.18

-

0.24

0.45

